header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

IN VITRO TESTING OF A REVISION HIP RECONSTRUCTION WITH IMPACTED TITANIUM PARTICLES (EORS AWARD FINALIST 2008)



Abstract

We investigated the feasibility of using porous titanium particles (TiP) to reconstruct femoral bone defects in revision hip replacement surgery in stead of using morzelised bone grafts. Questions regarding handling, initial stability and titanium particle release were addressed.

Seven composite femurs (Sawbones) were reamed and filled, stepwise, with 32 grams of large (Ø 3.15 – 4 mm) and 9 grams of smaller (Ø 2.8 – 3.15 mm) pure, 85% porous TiP. Subsequently an Exeter stem was cemented into the graft layer. All reconstructions were loaded axially (0–3000 N) for 300,000 loading cycles at 2 Hz. Subsidence of the stem was measured with radio stereometric analysis (RSA) and possible titanium particle release was measured using the laser diffraction technique.

The TiP were impacted into a > 3 mm (SD 1.43 mm) thick, highly entangled, graft layer. An average cement mantle of > 2 mm (SD 0.86 mm) was measured and little cement penetration was observed. The average subsidence of only 0.45 mm (SD 0.04 mm) was measured after 300 000 loading cycles. Most titanium particles were found directly after impaction. Most of these particles (87%) were smaller than 10 μm and could therefore be potentially harmful since they can induce osteolysis.

We can conclude that:

  1. A graft layer of impacted TiP can be constructed,

  2. The graft layer is stable enough to initially support a cemented Exeter stem,

  3. Titanium particles are released during impaction.

These data warrant further animal tests to assess the biological response to these released impaction particles. Also, animal tests should clarify possible particle release upon loading and its effects.

Correspondence should be addressed to EORS Secretariat Mag. Gerlinde M. Jahn, c/o Vienna Medical Academy, Alserstrasse 4, 1090 Vienna, Austria. Fax: +43-1-4078274. Email: eors@medacad.org